<DOC>
	<DOCNO>NCT02252497</DOCNO>
	<brief_summary>The purpose study compare single preoperative dose 1g tranexamic acid ( TXA ) versus preoperative dose 1g TXA follow continuous infusion 1g height hour blood loss .</brief_summary>
	<brief_title>Tranexamic Acid Total Hip Arthroplasty .</brief_title>
	<detailed_description>The purpose study compare single preoperative dose 1g tranexamic acid ( TXA ) versus preoperative dose 1g TXA follow continuous infusion 1g eight hour blood loss . The efficacy TXA blood loss greatly influence time administration relative surgery . In total hip arthroplasty , TXA start surgery . However optimal duration TXA administration hip arthroplasty unknown . Numerous study show single preoperative administration TXA effective . Yet indirect comparison indicate high efficacy TXA start surgery follow continuous infusion repeat bolus . Our hypothesis single preoperative administration TXA sufficient maintain therapeutic concentration TXA postoperative period . In addition pharmacokinetic/pharmacodynamic study perform identify contribution TXA plasma concentration predictor blood loss .</detailed_description>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patient require hip arthroplasty first line , except recent hip fracture ( le 3 month ) Consent patient family member support person . Contraindication tranexamic acid . Contraindication apixaban . Pregnancy . Patient receive curative anticoagulating treatment preoperative period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>hip arthroplasty</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>randomize control trial</keyword>
</DOC>